BRCA1 and small cell lung carcinoma: Classical HR deficiency due to HR pathway member mutation (i.e., BRCA1/2) is rare in SCLC (Sato et al, 2013; George et al, 2015; Farago et al, 2019; Simpson et al, 2020).